<DOC>
	<DOCNO>NCT02780752</DOCNO>
	<brief_summary>Primary sclerosing cholangitis ( PSC ) chronic inflammatory disease biliary duct liver result destruction fibrosis . PSC associate increase serum level hyaluronan ( HA ) , extracellular matrix polymer know drive inflammation multiple tissue disease model . Inhibition HA synthesis oral hymecromone show prevent progression autoimmunity several animal model . This prospective , open-label , single-center , pilot safety study hymecromone adult 18 year age old diagnose primary sclerosing cholangitis without evidence hepatic fibrosis . Participants treat 6 month study drug . Safety biomarkers response monitor therapy .</brief_summary>
	<brief_title>A Study Oral Hymecromone Treat Adults With Primary Sclerosing Cholangitis</brief_title>
	<detailed_description />
	<mesh_term>Cholangitis</mesh_term>
	<mesh_term>Cholangitis , Sclerosing</mesh_term>
	<criteria>Age 18 year old Diagnosis primary sclerosing cholangitis confirm liver biopsy and/or image study ( MRI cholangiography endoscopic retrograde cholangiopancreatography ) Gammaglutamyl transferase ( GGT ) Alkaline phosphatase &gt; 1.5 time upper limit normal If history endoscopically confirm inflammatory bowel disease , currently stable base HarveyBradshaw index â‰¤ 2 , normal inflammatory marker ( ESR , Creactive protein , fecal calprotectin ) stable nonexcluded medical therapy least 6 month . Not currently take vancomycin least 3 month prior enrollment . Patients vancomycin stop 3 month screen enrollment . Not currently take ursodiol least 3 month prior enrollment . Patients ursodiol stop 3 month screen enrollment . Currently receive biologic therapy ( i.e . infliximab , adalimumab , golimumab , etc . ) steroid medication inflammatory bowel disease Known allergy hymecromone Established hepatic biliary fibrosis Cholangiocarcinoma Pregnancy Physician concern participant may adhere study protocol , base prior behavior</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>